2020 Fourth Quarter Revenues of $249.0 Million, down 3.1% year-over-year
Q4 Diluted EPS (GAAP) of $0.94, up from $0.62 in Q4 of 2019
Q4 Adjusted Diluted EPS (Non-GAAP) (1) of $1.14, up from $0.79 in Q4 of 2019

2020 Revenues of $958.4 Million, down 3.3% year-over-year
2020 Diluted EPS (GAAP) of $2.59, up from $1.95 in 2019
2020 Adjusted Diluted EPS (Non-GAAP) (1) of $3.53, up from $3.09 in 2019

NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a leading operations management and analytics company, today announced its financial results for the quarter and full year ended December 31, 2020.

Rohit Kapoor, Vice Chairman and Chief Executive Officer, said, “EXL had a strong fourth quarter with revenue of $249.0 million and full year revenue of $958.4 million. Our adjusted diluted EPS for the year was a record $3.53, a 14% increase. 2020 was a transformative year for EXL. We proved the resiliency of our business model by effectively navigating pandemic related challenges. We focused on employee safety, strengthened our client relationships and expanded our profit margins. Our strengths in operations management, digital transformation and analytics are resonating with clients as they pursue their strategic goals in the new market environment. We see opportunities to grow revenue and profitability with a robust pipeline as we look ahead to 2021.”

Maurizio Nicolelli, Chief Financial Officer, said, “We ended 2020 with good momentum in our business and a very healthy balance sheet. In 2020, we generated $203.0 million in cash flow from operations and ended the year with $403.0 million in cash and short-term investments. Total borrowings were $239.0 million with a net cash position of $164.0 million. Our 2021 guidance follows the medium term targets we communicated at our investor day in November 2020. We expect 2021 revenue to be in the range of $1.04 billion to $1.06 billion, representing a 9% to 11% increase year-over-year. We expect adjusted diluted EPS to be in the range of $3.90 to $4.05, representing a 10% to 15% increase over the prior year.”

  1. Reconciliations of adjusted (non-GAAP) financial measures to GAAP measures are included at the end of this release.

Financial Highlights: Fourth Quarter 2020

Effective January 1, 2020, we made certain operational and structural changes to manage and report financial information through our four reportable segments: Insurance, Healthcare, Emerging Business and Analytics. Financial information for historical periods are recast to conform to the current presentation. For details regarding the change in segments, refer to our report on Form 10-K for the year ended December 31, 2020.

  • Revenues for the quarter ended December 31, 2020 decreased to $249.0 million compared to $256.9 million for the fourth quarter of 2019, a decrease of 3.1% on both reported basis and on a constant currency basis from the fourth quarter of 2019. Revenues increased by 3.3% sequentially on a reported basis and 3.1% on a constant currency basis, from the third quarter of 2020.

    Revenues   Gross Margin
    Three months ended   Three months ended
    December
31, 2020

  December
31, 2019

  September
30, 2020

  December
31, 2020
  December
31, 2019
  September
30, 2020
Reportable Segments  
    (dollars in millions)            
Insurance   $ 88.9     $ 88.5     $ 87.8     35.9 %   30.3 %   35.3 %
Healthcare     24.2       27.9       25.1     34.2 %   24.3 %   28.4 %
Emerging Business     37.8       46.8       37.6     45.0 %   43.6 %   44.7 %
Analytics     98.1       93.7       90.5     41.7 %   37.0 %   37.6 %
Total revenues, net   $ 249.0     $ 256.9     $ 241.0     39.4 %   34.5 %   36.9 %
  • Operating income margin for the quarter ended December 31, 2020 was 15.4%, compared to an operating income margin of 9.1% for the fourth quarter of 2019 and operating income margin of 14.3% for the third quarter of 2020. During the quarter ended December 31, 2019, we recorded impairment and restructuring charges of $1.4 million related to the wind down of the Health Integrated business, which reduced our operating income margin by 50 basis points. Adjusted operating income margin for the quarter ended December 31, 2020 was 19.7% compared to 13.3% for the fourth quarter of 2019 and 19.2% for the third quarter of 2020.

  • Diluted earnings per share for the quarter ended December 31, 2020 was $0.94 compared to $0.62 for the fourth quarter of 2019 and $0.76 for the third quarter of 2020. During the quarter ended December 31, 2019, we recorded impairment and restructuring charges of $1.4 million related to the wind down of the Health Integrated business, which reduced our diluted earnings per share by $0.03. Adjusted diluted earnings per share for the quarter ended December 31, 2020 was $1.14 compared to $0.79 for the fourth quarter of 2019 and $1.04 for the third quarter of 2020.

Financial Highlights: Full Year 2020

  • Revenues for the year ended December 31, 2020 decreased to $958.4 million compared to $991.3 million for the year ended December 31, 2019, a decrease of 3.3% on a reported basis and 3.0% on a constant currency basis.

    Revenues   Gross Margin
    Year ended   Year ended
    December 31,
2020
  December 31,
2019

  December 31,
2020
  December 31,
2019
Reportable Segments  
    (dollars in millions)    
Insurance   $ 341.8     $ 346.4     32.2 %   31.1 %
Healthcare   101.2     97.5     27.8 %   20.9 %
Emerging Business   152.7     190.1     41.4 %   42.9 %
Analytics   362.7     357.3     36.7 %   35.3 %
Total Revenues, net   $ 958.4     $ 991.3     34.9 %   33.9 %
  • Operating income margin for the year ended December 31, 2020 was 11.5% compared to 7.7% for the year ended December 31, 2019. During the year 2019, we recorded impairment and restructuring charges of $8.7 million related to the wind down of the Health Integrated business, which reduced our operating income margin by approximately 90 basis points. Adjusted operating income margin for the year ended December 31, 2020 was 15.9% compared to 13.4% for the year ended December 31, 2019.

  • Diluted earnings per share for the year ended December 31, 2020 was $2.59 compared to $1.95 for the year ended December 31, 2019. During the year 2019, we recorded impairment and restructuring charges of $8.7 million related to the wind down of the Health Integrated business, which reduced our diluted earnings per share by $0.19. Adjusted diluted earnings per share for the year ended December 31, 2020 was $3.53 compared to $3.09 for the year ended December 31, 2019.

  • During the quarter ended March 31, 2020, COVID-19 did not have a significant impact on our business, however, in subsequent quarters, COVID-19 materially impacted us. We took actions to adapt our delivery to a “work from home” model while also focusing on helping our employees and instituting temporary cost reduction measures, certain of which were reversed as of December 31, 2020. Additional information on the impacts of COVID-19 on our business will be included in our upcoming Annual Report on Form 10-K for the year ended December 31, 2020.

Business Highlights: Fourth Quarter 2020

  • Won 15 new clients in the fourth quarter of 2020, with nine in our operations management businesses and six in Analytics. For 2020, we won 45 new clients, with 22 in operations management businesses and 23 in Analytics.
  • Recognized as a Leader in The Forrester Wave™: Insights-Driven Business Process Outsourcing, Q4 2020.
  • Positioned as a Leader in the Everest Group Advanced Analytics & Insights (AA&I) Services PEAK Matrix® Assessment 2021.

2021 Guidance
Based on current visibility, and a U.S. Dollar to Indian Rupee exchange rate of 73.0, British Pound to U.S. Dollar exchange rate of 1.39, U.S. Dollar to the Philippine Peso exchange rate of 48.0 and all other currencies at current exchange rates, we are providing the following 2021 guidance:

  • Revenue of $1.04 billion to $1.06 billion, representing an increase of 9% to 11% on a reported basis, and 8% to 10% on a constant currency basis, from 2020.

  • Adjusted diluted earnings per share of $3.90 to $4.05, representing an increase of 10% to 15% from 2020.

Conference Call

ExlService Holdings, Inc. will host a conference call on Thursday, February 25, 2021 at 8:00 A.M. ET to discuss the Company’s quarterly operating and financial results. The conference call will be available live via the internet by accessing the investor relations section of EXL’s website at ir.exlservice.com, where an accompanying investor-friendly spreadsheet of historical operating and financial data can also be accessed. Please access the website at least fifteen minutes prior to the call to register, download and install any necessary audio software.

To listen to the conference call via phone, please dial 1-877-303-6384, or if dialing internationally, 1-224-357-2191 and an operator will assist you. For those who cannot access the live broadcast, a replay will be available on the EXL website ir.exlservice.com for a period of twelve months.

About ExlService Holdings, Inc.

EXL (NASDAQ: EXLS) is a leading operations management and analytics company that helps our clients build and grow sustainable businesses. By orchestrating our domain expertise, data, analytics and digital technology, we look deeper to design and manage agile, customer-centric operating models to improve global operations, drive profitability, enhance customer satisfaction, increase data-driven insights, and manage risk and compliance. Headquartered in New York, EXL has approximately 31,900 professionals in locations throughout the United States, the United Kingdom, Europe, India, the Philippines, Colombia, Canada, Australia and South Africa. EXL serves customers in multiple industries including insurance, healthcare, banking and financial services, utilities, travel, transportation and logistics, media and retail, among others. For more information, visit www.exlservice.com.

Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to EXL's operations and business environment, all of which are difficult to predict and many of which are beyond EXL’s control. Forward-looking statements include information concerning EXL’s possible or assumed future results of operations, including descriptions of its business strategy. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that we have made in light of management's experience in the industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. You should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although EXL believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect EXL’s actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors, which include our ability to successfully close and integrate strategic acquisitions, our ability to respond to and manage public health crises, including the outbreak and continued effects of the coronavirus (COVID-19) pandemic, are discussed in more detail in EXL’s filings with the Securities and Exchange Commission, including EXL’s Annual Report on Form 10-K. These risks could cause actual results to differ materially from those implied by forward-looking statements in this release. You should keep in mind that any forward-looking statement made herein, or elsewhere, speaks only as of the date on which it is made. New risks and uncertainties come up from time to time, and it is impossible to predict these events or how they may affect EXL. EXL has no obligation to update any forward-looking statements after the date hereof, except as required by federal securities laws.


EXLSERVICE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except share and per share amounts)

      (Unaudited)
  Year ended December 31,   Three months ended December 31,
  2020   2019   2020   2019
Revenues, net $ 958,434     $ 991,346     $ 248,953     $ 256,872  
Cost of revenues (1) 623,936     655,490     150,792     168,262  
Gross profit (1) 334,498     335,856     98,161     88,610  
Operating expenses:              
General and administrative expenses 113,891     126,909     29,390     33,560  
Selling and marketing expenses 60,123     71,842     17,326     17,846  
Depreciation and amortization expense 50,462     51,981     13,182     12,515  
Impairment and restructuring charges     8,671         1,375  
Total operating expenses 224,476     259,403     59,898     65,296  
Income from operations 110,022      76,453     38,263     23,314  
Foreign exchange gain, net 4,432     3,752     980     281  
Interest expense (11,190 )   (13,612 )   (2,607 )   (2,986 )
Other income, net 12,065     16,507     2,826     3,419  
Income before income tax expense and earnings from equity affiliates 115,329     83,100      39,462     24,028  
Income tax expense 25,626     15,172     7,209     2,601  
Income before earnings from equity affiliates 89,703     67,928     32,253     21,427  
Loss from equity-method investment 227     269     35     71  
Net income attributable to ExlService Holdings, Inc. stockholders $ 89,476     $ 67,659     $ 32,218     $ 21,356  
Earnings per share attributable to ExlService Holdings, Inc. stockholders:              
Basic $ 2.61     $ 1.97     $ 0.95     $ 0.62  
Diluted $ 2.59     $ 1.95     $ 0.94     $ 0.62  
Weighted-average number of shares used in computing earnings per share attributable to ExlService Holdings Inc. stockholders:              
Basic 34,273,388     34,350,150     33,882,013     34,253,308  
Diluted 34,555,164     34,732,683     34,370,023     34,696,896  

(1)Exclusive of depreciation and amortization expense.


EXLSERVICE HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)

    As of
    December 31, 2020   December 31, 2019
         
Assets        
Current assets:        
Cash and cash equivalents   $ 218,530       $ 119,165    
Short-term investments   184,286       202,238    
Restricted cash   4,690       5,453    
Accounts receivable, net   147,635       171,864    
Prepaid expenses   11,344       13,246    
Advance income tax, net   5,684       4,698    
Other current assets   37,109       24,594    
Total current assets   609,278       541,258    
Property and equipment, net   92,875       79,142    
Operating lease right-of-use assets   91,918       86,396    
Restricted cash   2,299       2,426    
Deferred tax assets, net   7,749       11,855    
Intangible assets, net   59,594       73,982    
Goodwill   349,088       349,529    
Other assets   32,099       36,016    
Investment in equity affiliate   2,957       2,484    
Total assets   $ 1,247,857       $ 1,183,088    
Liabilities and stockholders’ equity        
Current liabilities:        
Accounts payable   $ 6,992       $ 6,564    
Current portion of long-term borrowings   25,000       40,867    
Deferred revenue   32,649       13,436    
Accrued employee costs   67,645       68,885    
Accrued expenses and other current liabilities   66,410       74,017    
Current portion of operating lease liabilities   18,894       24,148    
Income taxes payable, net   3,488       1,432    
Total current liabilities   221,078       229,349    
Long-term borrowings, less current portion   201,961       194,131    
Operating lease liabilities, less current portion   84,874       74,709    
Income taxes payable   1,790       1,790    
Deferred tax liabilities, net   847       966    
Other non-current liabilities   18,135       12,142    
Total liabilities   528,685       513,087    
Commitments and contingencies        
Preferred stock, $0.001 par value; 15,000,000 shares authorized, none issued            
ExlService Holdings, Inc. Stockholders’ equity:        
Common stock, $0.001 par value; 100,000,000 shares authorized, 38,968,053 shares issued and 33,559,435 shares outstanding as of December 31, 2020 and 38,480,654 shares issued and 34,185,241 shares outstanding as of December 31, 2019   39       39    
Additional paid-in capital   420,976       391,240    
Retained earnings   641,379       551,903    
Accumulated other comprehensive loss   (74,984 )     (84,892 )  
Total including shares held in treasury   987,410       858,290    
Less: 5,408,618 shares as of December 31, 2020 and 4,295,413 shares as of December 31, 2019, held in treasury, at cost   (268,238 )     (188,289 )  
Stockholders' equity   719,172       670,001    
Total equity   719,172       670,001    
Total liabilities and stockholders’ equity   $ 1,247,857       $ 1,183,088    

EXLSERVICE HOLDINGS, INC.

Reconciliation of Adjusted Financial Measures to GAAP Measures

In addition to its reported operating results in accordance with U.S. generally accepted accounting principles (GAAP), EXL has included in this release certain financial measures that are considered non-GAAP financial measures, including the following:

(i)    Adjusted operating income and adjusted operating income margin;
(ii)   Adjusted EBITDA and adjusted EBITDA margin;
(iii)  Adjusted net income and adjusted diluted earnings per share; and
(iv)  Revenue growth on a constant currency basis.

These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles, should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, the financial results calculated in accordance with GAAP and reconciliations from those financial statements should be carefully evaluated. EXL believes that providing these non-GAAP financial measures may help investors better understand EXL’s underlying financial performance. Management also believes that these non-GAAP financial measures, when read in conjunction with EXL’s reported results, can provide useful supplemental information for investors analyzing period-to-period comparisons of the Company’s results and comparisons of the Company’s results with the results of other companies. Additionally, management considers some of these non-GAAP financial measures to determine variable compensation of its employees. The Company believes that it is unreasonably difficult to provide its earnings per share financial guidance in accordance with GAAP, or a qualitative reconciliation thereof, for a number of reasons, including, without limitation, the Company’s inability to predict its future stock-based compensation expense under ASC Topic 718, the amortization of intangibles associated with further acquisitions and the currency fluctuations and associated tax impacts. As such, the Company presents guidance with respect to adjusted diluted earnings per share. The Company also incurs significant non-cash charges for depreciation that may not be indicative of the Company’s ability to generate cash flow.

EXL non-GAAP financial measures exclude, where applicable, stock-based compensation expense, amortization of acquisition-related intangible assets, impairment charges of acquired long-lived and intangible assets including goodwill, provision for litigation settlement, non-cash interest expense on convertible senior notes, restructuring charges and other acquisition-related expenses or benefits. Acquisition-related expenses or benefits include, changes in the fair value of earn-out consideration liabilities, external deal costs, integration expenses, direct and incremental travel costs and non-recurring benefits. In addition to excluding the above items, our adjusted net income and adjusted diluted EPS also excludes the effect any non-recurring tax adjustments and income tax impact of the above pre-tax items, as applicable. The income tax impact of each item is calculated by applying the statutory rate and local tax regulations in the jurisdiction in which the item was incurred.

A limitation of using non-GAAP financial measures versus financial measures calculated in accordance with GAAP is that non-GAAP financial measures do not reflect all of the amounts associated with our operating results as determined in accordance with GAAP and exclude costs that are recurring, namely stock-based compensation and amortization of acquisition-related intangible assets. EXL compensates for these limitations by providing specific information regarding the GAAP amounts excluded from non-GAAP financial measures to allow investors to evaluate such non-GAAP financial measures.

The information provided on a constant currency basis reflects a comparison of current period results translated at the prior period currency rates. This information is provided because EXL believes that it provides useful comparative incremental information to investors regarding EXL’s true operating performance. EXL’s primary exchange rate exposure is with the Indian Rupee, the U.K. pound sterling and the Philippine Peso. The average exchange rate of the U.S. Dollar against the Indian Rupee increased from 71.35 during the quarter ended December 31, 2019 to 73.74 during the quarter ended December 31, 2020, representing an appreciation of 3.4%. The average exchange rate of the U.S. Dollar against the Philippine Peso decreased from 50.73 during the quarter ended December 31, 2019 to 48.16 during the quarter ended December 31, 2020, representing a depreciation of 5.1%. The average exchange rate of the British Pound against the U.S. Dollar increased from 1.30 during the quarter ended December 31, 2019 to 1.33 during the quarter ended December 31, 2020, representing a depreciation of 2.2%.

The following table shows the reconciliation of these non-GAAP financial measures for the year ended December 31, 2020 and 2019, the three months ended December 31, 2020 and 2019 and the three months ended September 30, 2020:


Reconciliation of Adjusted Operating Income and Adjusted EBITDA
(Amounts in thousands)

    Year ended   Three months ended
    December 31,   December 31,   September 30,
    2020   2019   2020   2019   2020
Net income (GAAP)   $ 89,476     $ 67,659     $ 32,218     $ 21,356     $ 26,418  
add: Income tax expense/(benefit)   25,626     15,172     7,209     2,601     8,490  
subtract: Interest expense, foreign exchange gain, net, loss from equity-method investment and other income, net   (5,080 )   (6,378 )   (1,164 )   (643 )   (502 )
Income from operations (GAAP)   $ 110,022     $ 76,453     $ 38,263     $ 23,314     $ 34,406  
add: Stock-based compensation expense   28,235     26,070     7,385     4,532     8,346  
add: Amortization of acquisition-related intangibles   14,412     21,558     3,415     4,974     3,413  
add: Impairment and restructuring charges (a)       8,671         1,375      
Adjusted operating income (Non-GAAP)   $ 152,669     $ 132,752     $ 49,063     $ 34,195     $ 46,165  
Adjusted operating income margin as a % of Revenues (Non-GAAP)   15.9  %   13.4  %   19.7  %   13.3  %   19.2  %
add: Depreciation   36,050     30,423     9,767     7,541     9,012  
Adjusted EBITDA (Non-GAAP)   $ 188,719     $ 163,175     $ 58,830     $ 41,736     $ 55,177  
Adjusted EBITDA margin as a % of revenue (Non-GAAP)   19.7  %   16.5  %   23.6  %   16.2  %   22.9  %

(a) To exclude impairment and restructuring charges related to wind down of the Health Integrated business.


Reconciliation of Adjusted Net Income and Adjusted Diluted Earnings Per Share
(Amounts in thousands, except per share data)

    Year ended   Three months ended
    December 31,   December 31,   September 30,
    2020   2019   2020   2019   2020
Net income (GAAP)   $ 89,476     $ 67,659     $ 32,218     $ 21,356     $ 26,418  
add: Stock-based compensation expense   28,235     26,070     7,385     4,532     8,346  
add: Amortization of acquisition-related intangibles   14,412     21,558     3,415     4,974     3,413  
add: Impairment and restructuring charges (a)       8,671         1,375      
add: Non-cash interest expense related to convertible senior notes   2,616     2,472     673     636     654  
subtract: Other non-recurring benefits (b)   (556 )   (761 )            
subtract: Effect of other non-recurring tax benefits (c)   (20 )   (3,134 )   (1,340 )   (1,663 )    
subtract: Tax impact on stock-based compensation expense (d)   (8,330 )   (7,986 )   (2,099 )   (2,144 )   (1,836 )
subtract: Tax impact on amortization of acquisition-related intangibles   (3,374 )   (4,621 )   (798 )   (1,042 )   (798 )
subtract: Tax impact on impairment and restructuring charges       (2,140 )       (352 )    
subtract: Tax impact on non-cash interest expense related to convertible senior notes   (648 )   (606 )   (168 )   (159 )   (162 )
add: Tax impact on other non-recurring benefits   137     186              
Adjusted net income (Non-GAAP)   $ 121,948     $ 107,368     $ 39,286     $ 27,513     $ 36,035  
Adjusted diluted earnings per share (Non-GAAP)   $ 3.53     $ 3.09     $ 1.14     $ 0.79     $ 1.04  

(a) To exclude impairment and restructuring charges related to wind down of the Health Integrated business.
(b) To exclude non-recurring benefits related to wind down of the Health Integrated business.
(c) To exclude non-recurring tax expense/(benefits) related to certain deferred tax assets and liabilities.
(d) Tax impact includes $2,378 and $2,306 for the year ended December 31, 2020 and 2019 respectively, $504 and $1,211 during the three months ended December 31, 2020 and 2019 respectively, and $52 during the three months ended September 30, 2020 related to discrete benefit recognized in income tax expense on adoption of ASU No. 2016-09, Compensation - Stock Compensation.

Contact: Steven N. Barlow
Vice President, Investor Relations
(917) 596-7684
ir@exlservice.com


Via GlobeNewswire RSS Feed https://ift.tt/3jYjx2z
Advertisements

Post a Comment

Previous Post Next Post
Like this content? Sign up for our daily newsletter to get latest updates.